StemCell Therapy

Michael West of BioTime on hES cell-based therapies - at Stem Cells USA RM Congress 2012
Michael West, CEO of BioTime, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Second generation hES cell-based therapies: achieving purity and scalability in the midst of diversity. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:23:31More inScience Technology

Here is the original post:
Michael West of BioTime on hES cell-based therapies - at Stem Cells USA

This entry was posted on December 22, 2012 at 1:44 am and is filed under Regenerative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |